Learn More
Selleck Chemical LLC Tivantinib (ARQ 197) 10mg 905854-02-6

Supplier: Selleck Chemical LLC S275310MG
Tivantinib (ARQ 197) is the first non-ATP-competitive c-Met inhibitor with Ki of 0.355 ?M in a cell-free assay, little activity to Ron, and no inhibition to EGFR, InsR, PDGFR? or FGFR1/4. Tivantinib (ARQ 197) induces a G2/M arrest and apoptosis. Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.